4Filed Feb 22, 7:00 PM ET

AVITA Medical (RCEL) CFO David D. O'Toole Buys 3,000 Shares

$RCEL · AVITA Medical, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

AVITA Medical (RCEL) CFO David D. O'Toole Buys 3,000 Shares

What Happened
David D. O'Toole, Chief Financial Officer of AVITA Medical, reported an open-market purchase of 3,000 shares on 2026-02-19 at $4.15 per share, for a total transaction value of $12,450. This transaction is a purchase, which some investors view as a positive signal since an insider is adding to their stake.

Key Details

  • Transaction date and price: 2026-02-19 — 3,000 shares at $4.15 each (total $12,450). Transaction type: P (purchase, open market or private purchase).
  • Filing date: Form 4 filed 2026-02-23 (filed within the standard two-business-day window).
  • Shares owned after transaction: Not specified in the provided filing excerpt. Footnote F1 notes that reported ownership includes unvested RSUs.
  • No 10b5-1 plan, cashless exercise, gift, or tax-withholding notes were indicated in the provided details.

Context
This was a straightforward open-market purchase rather than an option exercise or award. The dollar size ($12.45k) is modest relative to many insider transactions; purchases can be informative but do not on their own prove future company performance. The filing appears timely under insider reporting rules.